Add BrightSurf on Google Email

Stem cell-derived 'mini-brains' reveal potential drug treatment for rare disorder

Researchers have identified a histone deacetylase inhibitor that reverses MECP2 alterations in mutant neurons, offering hope for treating the devastating neurological disorder. The breakthrough uses stem cell-derived 'mini-brains' to screen potential drug libraries, providing an efficient method for finding effective treatments.

SourceUniversity of California - San Diego·JournalMolecular Psychiatry·DateSep 8, 2015

Breakthrough in 'marriage-broker' protein

Scientists at McGill University have made a breakthrough in understanding the role of Netrin1, a protein that brings cells together and maintains their healthy relationships. The study used genetic technology to remove all Netrin1 from mouse embryos, revealing a greater disruption of the nervous system than previously thought.

SourceMcGill University·JournalCell Reports·DateAug 12, 2015

NYSCF Global Stem Cell ArrayTM brings precision medicine one step closer to the clinic

Researchers designed a revolutionary high-throughput robotic platform to automate the process of generating patient-specific stem cells, reducing variability and increasing scale. This technology allows for 'clinical trials in a dish' and can identify potential drug metabolism and toxicity issues in human cells before clinical trials.

SourceNew York Stem Cell Foundation·JournalNature Methods·DateAug 3, 2015

Imaging glucose uptake activity inside single cells

A new approach to visualize glucose uptake activity in single living cells has been developed by Columbia University researchers. This technique uses stimulated Raman scattering imaging with a small alkyne tag to generate a strong Raman signal, allowing for high-sensitivity imaging of glucose uptake at the cellular level.

SourceColumbia University·JournalAngewandte Chemie International Edition·DateJul 17, 2015

Uncovering a key relationship in ALS

A University of Toronto research team discovered a new link between the genetic cause of ALS and its pathology, suggesting that C9orf72's mislocalization leads to TDP-43 buildup. This breakthrough offers new avenues for research and potential treatment or cure.

SourceUniversity of Toronto·JournalAnnals of Neurology·DateJul 15, 2015

How your brain knows it's summer

A study published in PNAS reveals that the neurotransmitter GABA plays a crucial role in encoding seasonal changes through changes in chloride levels. By blocking GABA activity, researchers were able to synchronize the brain's internal clock, suggesting a potential therapeutic strategy for individuals with disrupted seasonal rhythms.

SourceRIKEN·JournalProceedings of the National Academy of Sciences·DateJun 29, 2015

Factors released following stem cell transplantation therapeutically impact serious burns

Stem cell transplantation has been shown to accelerate healing in laboratory rats with severe burns. The treatment uses bone marrow-derived mesenchymal stromal cells (MSCs), which enhanced local blood supply, modulated the immune system, and secreted growth factors with anti-inflammatory properties.

New sleep genes found

Scientists at Thomas Jefferson University have identified two new genes, taranis and Cyclin-dependent kinase 1 (Cdk1), as crucial for regulating normal sleep patterns in flies. The researchers found that these genes interact with other proteins to create a molecular machine that suppresses wakefulness and promotes sleep.

SourceThomas Jefferson University·JournalCurrent Biology·DateJun 18, 2015

Beyond average

Researchers have developed high-throughput techniques to quickly and easily give every cell in a sample a unique genetic barcode, enabling scientists to analyze complex tissues at the single-cell level. This breakthrough allows for deeper understanding of cell diversity and gene expression.

SourceHarvard Medical School·JournalCell·DateMay 21, 2015

Premature aging: Scientists identify and correct defects in diseased cells

Researchers have identified and corrected defects in diseased cells, restoring normal activity in Cockayne syndrome patients. The study reveals the role of an enzyme, HTRA3 protease, in mitochondrial defects that contribute to premature aging. Therapeutic strategies using HTRA3 inhibitors or antioxidants may soon be tested in patients.

SourceInstitut Pasteur·JournalProceedings of the National Academy of Sciences·DateMay 21, 2015